UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of Brier score to assess binary predictions

Journal of clinical epidemiology, 2010-08, Vol.63 (8), p.938-939

Rufibach, Kaspar

2010

Volltextzugriff (PDF)

Treatment effect quantification for time‐to‐event endpoints–Estimands, analysis strategies, and beyond

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2019-03, Vol.18 (2), p.145-165

Rufibach, Kaspar

2019

Volltextzugriff (PDF)

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

The New England journal of medicine, 2017-10, Vol.377 (14), p.1331-1344

2017

Volltextzugriff (PDF)

Joint modeling of progression‐free and overall survival and computation of correlation measures

Statistics in medicine, 2019-09, Vol.38 (22), p.4270-4289

2019

Volltextzugriff (PDF)

Survival analysis for AdVerse events with VarYing follow‐up times (SAVVY): Rationale and statistical concept of a meta‐analytic study

Biometrical journal, 2021-03, Vol.63 (3), p.650-670

2021

Volltextzugriff (PDF)

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY): summary of findings and assessment of existing guidelines

Trials, 2024-05, Vol.25 (1), p.353-10, Article 353

2024

Volltextzugriff (PDF)

Principal stratum strategy: Potential role in drug development

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2021-07, Vol.20 (4), p.737-751

2021

Volltextzugriff (PDF)

Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials

Statistics in medicine, 2022-02, Vol.41 (5), p.877-890

2022

Volltextzugriff (PDF)

Integrating phase 2 into phase 3 based on an intermediate endpoint while accounting for a cure proportion—With an application to the design of a clinical trial in acute myeloid leukemia

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2020-01, Vol.19 (1), p.44-58

2020

Volltextzugriff (PDF)

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?

Journal of patient-reported outcomes, 2020-08, Vol.4 (1), p.68-8, Article 68

2020

Volltextzugriff (PDF)

Quantification of follow‐up time in oncology clinical trials with a time‐to‐event endpoint: Asking the right questions

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2023-07, Vol.22 (4), p.671-691

2023

Volltextzugriff (PDF)

logcondens : Computations Related to Univariate Log-Concave Density Estimation

Journal of statistical software, 2011-03, Vol.39 (6)

2011

Volltextzugriff (PDF)

A multistate model for early decision‐making in oncology

Biometrical journal, 2020-05, Vol.62 (3), p.550-567

2020

Volltextzugriff (PDF)

A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials

The American statistician, 2021, Vol.75 (4), p.424-432

2021

Volltextzugriff (PDF)

Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting

Frontiers in pharmacology, 2024, Vol.15, p.1223858

2024

Volltextzugriff (PDF)

Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry

Heart (British Cardiac Society), 2013-07, Vol.99 (14), p.1034-1040

2013

Volltextzugriff (PDF)

Estimands in hematologic oncology trials

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2021-07, Vol.20 (4), p.793-805

2021

Volltextzugriff (PDF)

Frequency and Anatomic Distribution of Magnetic Resonance Imaging Features in the Sacroiliac Joints of Young Athletes

Arthritis & rheumatology (Hoboken, N.J.), 2018-05, Vol.70 (5), p.736-745

2018

Volltextzugriff (PDF)

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Journal of clinical oncology, 2007-08, Vol.25 (22), p.3217-3223

2007

Volltextzugriff (PDF)

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)—estimation of adverse event risks

Trials, 2021-06, Vol.22 (1), p.420-420, Article 420

2021

Volltextzugriff (PDF)

Estimands for overall survival in clinical trials with treatment switching in oncology

Pharmaceutical statistics : the journal of the pharmaceutical industry, 2022-01, Vol.21 (1), p.150-162

2022

Volltextzugriff (PDF)

Global functioning and disability in dissociative disorders

Psychiatry research, 2012-12, Vol.200 (2), p.475-481

2012

Volltextzugriff (PDF)

Statins and the Risk of Cancer After Heart Transplantation

Circulation (New York, N.Y.), 2012-07, Vol.126 (4), p.440-447

2012

Volltextzugriff (PDF)

Does evaluation of the ligamentous compartment enhance diagnostic utility of sacroiliac joint MRI in axial spondyloarthritis?

Arthritis research & therapy, 2015-09, Vol.17 (1), p.246-246, Article 246

2015

Volltextzugriff (PDF)

Trainee satisfaction in surgery residency programs: Modern management tools ensure trainee motivation and success

Surgery, 2012-11, Vol.152 (5), p.794-801

2012

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(110)

Publikationsform

Artikel
(117)
Reviews
(1)

Sprache

Englisch
(117)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(82)
Humans
(63)
Female
(44)
Male
(44)
Mathematics
(36)
Physical Sciences
(36)
Statistics & Probability
(36)
Middle Aged
(35)
Adult
(32)
Aged
(26)
Biological And Medical Sciences
(19)
Medical Sciences
(19)
Rheumatology
(16)
Mathematical & Computational Biology
(15)
Young Adult
(15)
Clinical Trials
(14)
Magnetic Resonance Imaging
(14)
Statistics
(14)
Adolescent
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of Brier score to assess binary predictions

Treatment effect quantification for time‐to‐event endpoints–Estimands, analysis strategies, and beyond

Obinutuzumab for the First-Line Treatment of Follicular Lymphoma

Joint modeling of progression‐free and overall survival and computation of correlation measures

Survival analysis for AdVerse events with VarYing follow‐up times (SAVVY): Rationale and statistical concept of a meta‐analytic study

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY): summary of findings and assessment of existing guidelines

Principal stratum strategy: Potential role in drug development

Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials

Integrating phase 2 into phase 3 based on an intermediate endpoint while accounting for a cure proportion—With an application to the design of a clinical trial in acute myeloid leukemia

What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?

Quantification of follow‐up time in oncology clinical trials with a time‐to‐event endpoint: Asking the right questions

logcondens : Computations Related to Univariate Log-Concave Density Estimation

A multistate model for early decision‐making in oncology

A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials

Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting

Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry

Estimands in hematologic oncology trials

Frequency and Anatomic Distribution of Magnetic Resonance Imaging Features in the Sacroiliac Joints of Young Athletes

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research

Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)—estimation of adverse event risks

Estimands for overall survival in clinical trials with treatment switching in oncology

Global functioning and disability in dissociative disorders

Statins and the Risk of Cancer After Heart Transplantation

Does evaluation of the ligamentous compartment enhance diagnostic utility of sacroiliac joint MRI in axial spondyloarthritis?

Trainee satisfaction in surgery residency programs: Modern management tools ensure trainee motivation and success

Suchergebnisse filtern